Abiopharma

Celebrate National Mentoring Month With SWE

New Form S-1 - SCWorx Corp. Filed: 2026-01-08 AccNo: 0001213900-26-002450 Size: 1 MB

Administrative update #SUPPL-1 for BIOCON BIOLOGICS INC. Status: Approval. Decision date: 01/07/2026

(81% Neutral) Salarius Pharmaceuticals, Inc. (SLRX) Announces Business Combination

📋 Tom Penny (Officer) plans to sell 7K shares of Equillium, Inc. (at $1.29 each, total $8K) Filed: Jan 08, 2026 | ID: 000001

New Form SCHEDULE 13G/A - DBV Technologies S.A. Filed: 2026-01-08 AccNo: 0001274173-26-000027 Size: 9 KB

New Form SCHEDULE 13G/A - BIOLIFE SOLUTIONS INC Filed: 2026-01-08 AccNo: 0001897612-26-000006 Size: 7 KB

New Form SCHEDULE 13G - Personalis, Inc. Filed: 2026-01-08 AccNo: 0001897612-26-000008 Size: 7 KB

New Form SCHEDULE 13G - Dyne Therapeutics, Inc. Filed: 2026-01-08 AccNo: 0001897612-26-000009 Size: 7 KB

MiNK Therapeutics and University of Wisconsin–Madison Announce Phase 1 Clinical Trial of Allo-iNKT Cell Therapy (AgenT-797) to Evaluate Prevention of Graft-Versus-Host Disease

New Form SCHEDULE 13G - Ovid Therapeutics Inc. Filed: 2026-01-08 AccNo: 0001623632-26-000052 Size: 45 KB

New Form 5 - CONMED Corp Filed: 2026-01-08 AccNo: 0000816956-26-000002 Size: 5 KB

The Latest from NRC Health | AI and the trust ecosystem, NRC Healths new podcast, and so much more!

Auxly Reviews 2025 Milestones and Provides 2026 Outlook

ALX Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference